Table 1. Primers.
HIV Primers used in this protocol | HXB2 bp | |||
Name | Sequence 5'-3' | bp | Start | End |
BEF1 | TAATAGCAATAGTTGTGTGG | 20 | 6,111 | 6,130 |
BEF2 | CAATAGTTGTGTGGTCCATAG | 21 | 6,117 | 6,137 |
BER2 | CAACAGATGCTGTTGCGC | 18 | 7,905 | 7,922 |
BNF1 | CTGGCTGTGGAAAGATACCT | 19 | 7,965 | 7,984 |
BNR1 | AGCTCCCAGGCTCAGATCT | 19 | 9,558 | 9,576 |
BNR2 | ATCTGAGGGCTCGCCACT | 18 | 9,488 | 95,05 |
Alternate Primers from Lamers et al., 2016 Sarcoma | HXB2 bp | |||
Name | Sequence 5'-3' | bp | Start | End |
EF2 | ACAGTCTATTATGGGGTRCC | 20 | 6,333 | 6,352 |
EF3 | CATAATGTTTGGGCCACACA | 20 | 6,420 | 6,439 |
ER1 | ATTCACTTCTCCAATTRTC | 19 | 7,653 | 7,671 |
NF1 | TTAGGCAGGGATAYTCACC | 19 | 8,347 | 8,365 |
NR1 | AGCTCCCAGGCTCAGATCT | 19 | 9,558 | 9,576 |
NR2 | ATCTGAGGGCTCGCCACT | 18 | 9,488 | 9,505 |